Review of commercially available nano-drugs and nano-delivery systems: challenges and perspectives | 4open

Volume 6 (2023)

4open, 6 (2023) 9

Full HTML

Open Access

Review

Table 1

Recent commercially available modifications and their main applications in nano-drugs and delivery systems.

Type of modification	Name^TM/®	Parent company	Main application	Reference
Chemical moiety	Norvir	Abbvie	Antiviral	[11]
Chemical moiety	Losentic	Novartis	Antihypertensive	[12]
Chemical moiety	Vasotec	Merck	Antihypertensive	[12]
Chemical moiety	Ceftin	GSK	Antibiotic	[13]
Chemical moiety	Cipro IV	Merck	Antibiotic	[16]
Supramolecular	BioPerine	Sabina Corp	Blood Sugar Lower	[17]
Supramolecular	Taxol	BMS	Antineoplastic	[20]
Supramolecular	Taxotere	Sanofi	Antineoplastic	[21]
Micelle/Emulsion	MyCell	Glow Life Tech	Lipophilic Drug Carrier	[22]
Micelle/Emulsion	Curepods	Cure Pharma	Lipophilic Drug Carrier	[23]
Micelle/Emulsion	uGOO	EmbarkoNano	Lipophilic Drug Carrier	[26]
Liposome	Cyclosome	Hi-Tech Pharma	Lipophilic Drug Carrier	[27]
Liposome	Phytosome	Indesa	Lipophilic Drug Carrier	[34]
Polymeric Nanoparticle	Genexol	Samyang	Antineoplastic	[35]
Nano Solid Dispersion	Sporanox	Janseen Pharma	Antifungal	[37]
Nano Solid Dispersion	Nimotop	Bayer	Antihypertensive	[38]
Inclusion Complex	Fenumat	Akay Ingredients	Lipophilic Drug Carrier	[44]
Inclusion Complex	CyLoc	Tesseract Medical Research	Cyclodextrin Cages as a Carrier	[45]
Inclusion Complex	SSRM	Folium Labs Corp	HA Dispersion as a Carrier	[52]